Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.

Chaparro, María

Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease. [electronic resource] - European journal of gastroenterology & hepatology 05 2020 - 588-596 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1473-5687

10.1097/MEG.0000000000001706 doi


Adalimumab--pharmacokinetics
Adult
Anti-Inflammatory Agents--pharmacokinetics
Antibodies, Monoclonal--blood
Crohn Disease--blood
Female
Humans
Induction Chemotherapy--methods
Infliximab--pharmacokinetics
Male
Necrosis
Prospective Studies
Remission Induction
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors